股东名称 是否 为控 股股 东 本次质押股 数（股） 是否为 限售股 （如 是，注 明限售 类型） 是 否 补 充 质 押 质押起 始日 质押 到期 日 质权人 占其 所持 股份 比例 占公司 总股本 比例 质押 融资 资金 用途 张家港市 朴鑫企业 管理咨询 合伙企业 （有限合 伙） 否 155,866,962 否 否 2024 年 10月31 日 至办 理解 除质 押登 记手 续之 日止 中 国 农 业 银 行 股 份 有 限 公 司 苏 州 长 三 角 一 体 化 示 范 区 分 行 100% 5.10% 股权 类投 资 1. 本次股份质押基本情况 证券代码：600226 证券简称：亨通股份 公告编号：2024-058 浙江亨通控股股份有限公司 关于持股 5%以上股东质押股份的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 张家港市朴鑫企业管理咨询合伙企业（有限合伙）持有公司无限售条件 流通股 155,866,962 股，占公司总股份数 5.10%，本次质押股份数量 155,866,962 股；本次 ...

内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《浙江亨通 控股股份有限公司 2024 年第三季度报告》。 二、关于修订《关于董事、监事和高级管理人员所持本公司股份及其变动的管理 办法》的议案； 浙江亨通控股股份有限公司 第九届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江亨通控股股份有限公司（以下简称"公司"）第九届董事会第十五次会议通 知于 2024 年 10 月 14 日以电子邮件和书面方式发出。会议于 2024 年 10 月 24 日以现 场结合通讯方式召开，会议应出席董事 9 人，实际出席董事 9 人,公司监事及高级管 理人员列席会议。本次会议由董事长崔巍先生主持。会议的召开符合《公司法》和《公 司章程》及有关法律、法规的要求。会议审议并以书面表决方式通过了如下议案： 一、2024 年第三季度报告； 表决结果：同意 9 票，反对 0 票，弃权 0 票。 本议案事先已经公司董事会审计委员会审议通过。 证券代码：600226 证券简称：亨通股份 公告编号：202 ...

浙江亨通控股股份有限公司 对外投资管理制度 第一章 总 则 第一条 目的：为规范浙江亨通控股股份有限公司（以下简称"公司"）对外 投资行为，防范对外投资风险，保证投资行为合法、审慎、安全、有效，提高对 外投资效益，根据《中华人民共和国公司法》（以下简称《公司法》）《上海证券 交易所股票上市规则》（以下简称《股票上市规则》）及《浙江亨通控股股份有限 公司章程》（以下简称《公司章程》）等相关规定，特制定本制度。 第二条 适用范围：公司及控股子公司。 第三条 定义： 1、对外投资指公司为实现获取未来收益而将公司的货币以及经资产评估后 的房屋、机器、设备、物资等实物，以及专利权、商标权、土地使用权等无形资 产作价出资等，进行各种形式的投资活动。 2、按照投资期限的长短，公司对外投资分为短期投资和长期投资。短期投 资主要指具有流动性且预期持有时间不准备超过一年（含一年）的投资，包括各 种股票、债券、基金、理财产品和分红型保险等；长期投资指不能随时变现或投 资期限超过一年的各种投资，包括但不限于下列类型：公司独资的企业或经营项 目；公司与其他独立法人或自然人合资、合作公司或开发项目；公司参股其他独 立法人实体。 第四条 ...

证券代码：600226 证券简称：亨通股份 公告编号：2024-057 浙江亨通控股股份有限公司 浙江亨通控股股份有限公司（以下简称"公司"）已于 2024 年 10 月 25 日发 布公司 2024 年第三季度报告，为便于广大投资者更全面深入地了解公司 2024 年 第三季度经营成果、财务状况，公司计划于 2024 年 11 月 12 日下午 16:00-17:00 举行 2024 年第三季度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2024 年第三季度的经营 成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范 围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 （一） 会议召开时间：2024 年 11 月 12 日下午 16:00-17:00 （二） 会议召开地点：上证路演中心 会议召开时间：2024 年 11 月 12 日(星期二)下午 16:00-17:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo ...

Financial Performance - Revenue for Q3 2024 reached ¥347,021,487.20, an increase of 119.45% year-over-year[2] - Net profit attributable to shareholders for Q3 2024 was ¥70,822,930.30, up 35.04% compared to the same period last year[2] - Operating income for the year-to-date period reached ¥908,204,370.68, a growth of 106.70% compared to the same period last year[2] - Total operating revenue for the first three quarters of 2024 reached ¥908,204,370.68, a significant increase from ¥439,391,684.64 in the same period of 2023, representing a growth of approximately 106.6%[14] - The net profit for the third quarter of 2024 was CNY 163,641,791.74, an increase from CNY 159,394,877.10 in the same period of 2023, reflecting a growth of approximately 1.4%[15] - The total profit for the third quarter of 2024 reached CNY 194,158,728.84, compared to CNY 175,284,946.95 in the previous year, indicating an increase of about 10.8%[15] - The company's operating profit for Q3 2024 was CNY 183,143,469.32, slightly up from CNY 175,407,406.04 in Q3 2023, marking a growth of around 4.2%[15] Assets and Liabilities - Total assets at the end of Q3 2024 amounted to ¥4,364,694,157.41, reflecting a 1.16% increase from the end of the previous year[3] - Total liabilities increased to ¥957,014,742.15 in Q3 2024 from ¥826,048,737.29 in Q3 2023, marking a rise of approximately 15.8%[13] - The equity attributable to shareholders of the parent company rose to ¥3,407,679,415.26 in Q3 2024, compared to ¥3,259,189,338.30 in Q3 2023, an increase of about 4.5%[14] - The company's long-term equity investments decreased to ¥1,538,908,975.62 in Q3 2024 from ¥1,616,723,843.93 in Q3 2023, a decline of approximately 4.8%[12] Cash Flow - Cash flow from operating activities for the first three quarters of 2024 was CNY 941,840,283.88, significantly higher than CNY 508,954,125.40 in the same period of 2023, representing an increase of approximately 84.8%[17] - The net cash flow from investing activities for the first three quarters of 2024 was -CNY 131,248,274.32, an improvement compared to -CNY 332,352,753.51 in the same period of 2023[18] - The company reported a decrease in cash and cash equivalents, with a net decrease of CNY 199,352,545.25 in Q3 2024, compared to a decrease of CNY 119,469,905.12 in Q3 2023[19] Shareholder Information - The total number of common shareholders at the end of the reporting period was 36,744[6] - The largest shareholder, Hengtong Group Co., Ltd., held 14.73% of the shares, with 270,298,280 shares pledged[6] - As of September 30, 2024, Zhejiang Hengtong Holdings Co., Ltd. repurchased 84,695,449 shares, accounting for 2.77% of the total share capital[8] - Hengtong Group Co., Ltd. remains the largest shareholder, holding 450,497,132 shares[7] Research and Development - Research and development expenses surged to ¥26,936,007.87 in 2024, up from ¥6,156,503.17 in 2023, reflecting a growth of approximately 338.5%[14] Other Financial Metrics - The basic earnings per share for Q3 2024 was ¥0.02, unchanged from the previous quarter[3] - The weighted average return on equity for Q3 2024 was 2.07%, an increase of 0.46 percentage points year-over-year[3] - Non-recurring gains and losses totaled ¥29,533,387.22 for Q3 2024, with significant contributions from government subsidies and asset disposals[4] - The company reported a significant increase in accounts receivable, rising to CNY 197,305,361.08 from CNY 67,594,710.24 in the previous period[11] - The company completed the acquisition of a 49% stake in Hengtong Precision Copper Foil Technology (Deyang) Co., Ltd. for CNY 29,296.00 million, resulting in 100% ownership[9] - The company has a bad debt provision of CNY 26,620.00 million related to overdue transaction intention funds[9] - The company has received CNY 12,349,367.52 in government subsidies related to the acquisition of Hengtong Copper Foil[10] - The company provided financial assistance of CNY 81,600,000 to Hengtong Copper Foil, which was repaid ahead of schedule[10] - The company completed the transfer of 100% equity of Chengdu Yanlong Technology Co., Ltd. for CNY 1.2 million[9] - The company is actively pursuing legal actions to recover overdue transaction intention funds, with a court ruling in its favor[9] - The company's cash and cash equivalents increased to ¥1,471,113,262.67 in Q3 2024, up from ¥1,357,838,526.92 in Q3 2023, reflecting a growth of approximately 8.3%[12] - The accounts payable increased to ¥252,705,040.11 in Q3 2024 from ¥244,891,751.18 in Q3 2023, indicating a rise of about 3.3%[13] - Deferred income increased to ¥80,277,183.43 in Q3 2024 from ¥57,683,593.40 in Q3 2023, representing a growth of about 39.0%[13] - The company recorded a foreign exchange gain of CNY 600,361.99 in Q3 2024, compared to a gain of CNY 663,877.26 in Q3 2023[19] - The company's total revenue from sales and services received in cash for the first three quarters of 2024 was CNY 782,337,539.21, compared to CNY 451,125,986.87 in the same period of 2023, indicating a growth of approximately 73.3%[17]

董事、监事和高级管理人员不得进行以本公司股票为标的证券的融资融券交 易。 浙江亨通控股股份有限公司 关于董事、监事和高级管理人员所持本公司股份 及其变动的管理办法 第一章 总 则 第一条 为加强对浙江亨通控股股份有限公司（以下简称："公司"或"本公 司"）董事、监事和高级管理人员等主体所持本公司股份及其变动的管理，根据 《中华人民共和国公司法》（以下简称《公司法》）《中华人民共和国证券法》 （以下简称《证券法》）《上市公司董事、监事和高级管理人员所持本公司股份 及其变动管理规则》《上海证券交易所股票上市规则》《上海证券交易所上市公 司自律监管指引第15号——股东及董事、监事、高级管理人员减持股份》等法律 法规、规范性文件的规定，结合公司实际情况，制定本管理办法。 第二条 本办法适用于公司董事、监事和高级管理人员所持本公司股份及其 变动的管理。其所持本公司股份是指登记在其名下和利用他人账户持有的所有本 公司股份；从事融资融券交易的,还包括记载在其信用证券账户内的本公司股份。 拥有多个证券账户的，应当合并计算，各账户可减持数量按各账户内有关股份数 量的比例分配确定。 第三条 公司董事、监事和高级管理人员在买卖公司 ...

证券代码：600226 证券简称：亨通股份 公告编号：2024-056 浙江亨通控股股份有限公司 关于 2024 年前三季度与行业相关的经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江亨通控股股份有限公司（以下简称"公司"）根据《上海证券交易所上市 公司自律监管指引第3号——行业信息披露(第十三号——化工)》要求，现将2024 年前三季度与行业相关的经营数据（未经审计）披露如下： 一、相关产品的产量、销量及收入实现情况 | 产品名称 | 产量（折百,吨） | 销量（折百,吨） | 营业收入(万元) | | | --- | --- | --- | --- | --- | | L-色氨酸 | 3,052.10 | 2,843.75 | | 16,122.35 | | 蒸汽 | 1,233,356.00 | 844,857.00 | | 19,365.79 | 二、相关产品和原材料的价格变动情况 （一）相关产品价格波动情况 | 产品名称 | 2024年1-9月平均 | 2023年1-9月平均售 | 变动比率 | | ...

证券代码：600226 证券简称：亨通股份 公告编号：2024-054 浙江亨通控股股份有限公司 关于全资子公司出售资产暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 浙江亨通控股股份有限公司（以下简称"公司"或"亨通股份"）全资子 公司浙江拜克生物科技有限公司（以下简称"拜克生物"）拟向公司关联方德清捷 欣科技有限公司（以下简称"捷欣科技"）转让位于浙江省湖州市德清县钟管镇横 塘桥路97号的房屋建筑物（包含土地使用权）（以下简称"房屋建筑物"），交易 双方结合资产评估结果协商确定本次转让价格为人民币3,032.34万元。 根据《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监 管指引第5号——交易与关联交易》的规定，本次交易构成关联交易，不构成《上市 公司重大资产重组管理办法》规定的重大资产重组。 本次交易事项已经公司第九届董事会第十四次会议审议通过；截至本次关 联交易为止，过去12个月内发生的需累计计算的公司与同一关联人或与不同关联人 之间相同交易类别下标的相关的关联交易金额累计 ...

证券代码：600226 证券简称：亨通股份 公告编号：2024-053 浙江亨通控股股份有限公司 诉讼进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 涉案金额：案件一：宁波梅山保税港区浆果晨曦新媒体投资中心(有限合伙)(以 下简称"浆果晨曦")应向公司返还第二期交易意向金 5,000 万元、支付资金使用费 67,460,021.92 元、支付违约金 167,796,300.00 元，合计 285,256,321.92 元（资金使 用费、违约金暂计至 2021 年 12 月 31 日），喻策对浆果晨曦的上述付款义务承担连带 清偿责任，承担连带责任后有权向浆果晨曦追偿。公司有权在 285,256,321.92 元范围 内，就浆果晨曦质押给公司的其持有的深圳量子云科技有限公司（以下简称"量子云"） 名下 75.5%股权（质权登记编号：202006083227）折价或者拍卖、变卖所得价款优先受 偿。 案件二：浆果晨曦向公司返还剩余交易意向金22,930万元及资金使用费（以27,930 万元为基数，自 2022 ...

Financial Performance - The company's operating revenue for the first half of 2024 reached RMB 561,182,883.48, representing a 99.52% increase compared to RMB 281,261,753.55 in the same period last year[13]. - The net profit attributable to shareholders of the listed company was RMB 116,558,808.95, a 6.24% increase from RMB 109,711,376.48 in the previous year[13]. - The net profit after deducting non-recurring gains and losses was RMB 110,893,168.73, reflecting an 11.86% increase from RMB 99,132,412.00 in the same period last year[13]. - The company's total assets increased by 6.64% to RMB 4,601,259,333.83 compared to RMB 4,314,615,988.81 at the end of the previous year[13]. - The net assets attributable to shareholders of the listed company rose by 4.92% to RMB 3,419,464,967.27 from RMB 3,259,189,338.30 at the end of the previous year[13]. - The basic earnings per share remained at RMB 0.04, while the diluted earnings per share also stayed at RMB 0.04, indicating stability in earnings[14]. - The weighted average return on net assets increased by 0.23 percentage points to 3.50% compared to 3.27% in the previous year[14]. - The growth in operating revenue was primarily driven by increased sales volume in the copper foil business[14]. - The company reported a net cash flow from operating activities of RMB -48,740,431.82, indicating a negative cash flow situation[13]. Business Segments - The company achieved operating revenue of 561.83 million, a year-on-year increase of 99.52%, primarily driven by growth in copper foil business sales volume and price[17]. - The copper foil business generated revenue of 240.49 million, accounting for 42.85% of total operating revenue[17]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, increased significantly due to the rise in veterinary drug product sales[17]. - The company’s biopharmaceutical segment reported a revenue of 319.45 million yuan, a year-on-year increase of 14.51%[25]. - The net profit from the biopharmaceutical segment was 60.23 million yuan, showing a significant year-on-year growth of 126.40%[25]. Investments and Acquisitions - The company completed the acquisition of the remaining 49% equity in Hengtong Copper Foil, making it a wholly-owned subsidiary, with the acquisition costing 292.96 million yuan[27]. - Hengtong Copper Foil generated a revenue of 240.49 million yuan, accounting for 42.85% of the company's total revenue[27]. - The company has invested in a 50,000 tons/year electrolytic copper foil project, indicating ongoing expansion in production capacity[36]. - The company has applied for a total of 48 patents, with 22 patents granted, enhancing its intellectual property portfolio[24]. Research and Development - Research and development expenses surged by 239.37% to ¥13.64 million, up from ¥4.02 million, primarily due to increased investment in copper foil business[28]. - The company has established a comprehensive quality management system for its copper foil production, ensuring product quality meets customer requirements[21]. - The company has developed over 40 pesticide formulations, focusing on environmentally friendly products for economic crops and fruit trees[22]. Market Trends and Strategies - The market for lithium battery copper foil is expected to continue growing, driven by demand from the new energy vehicle sector, with a projected increase in shipments[18]. - The global PCB industry is forecasted to reach a market value of 1,015.6 billion by 2026, with a compound annual growth rate of 4.6%[18]. - The company is focusing on high-end copper foil production to reduce reliance on imports, as domestic production capacity for high-end products remains insufficient[18]. - The veterinary medicine and feed additive business is closely linked to the livestock industry's development, with a stable demand for animal feed products[18]. - The company is adapting to market changes by implementing strategies to reduce soybean meal usage in animal feed, aiming for a decrease of over 0.5 percentage points annually until 2025[18]. Environmental and Social Responsibility - The company’s wastewater treatment meets the standards, with COD levels at ≤ 42 mg/L, below the limit of ≤ 50 mg/L[59]. - The company’s ammonia nitrogen (NH3-N) concentration is ≤ 1.0 mg/L, well below the standard limit of ≤ 5 mg/L[59]. - The company has established a wastewater treatment center with a capacity of 8000T/D, including a 2400T/D anaerobic pretreatment system and a 4000T/D high-concentration pretreatment system[61]. - The company has implemented a comprehensive waste management system, ensuring that all hazardous waste is disposed of by qualified units and that general solid waste is utilized properly[60]. - The company continues to promote green development and expand investments in the energy sector in response to national energy policies[69]. Corporate Governance - The company’s governance structure was confirmed to comply with the Company Law and Articles of Association, ensuring all resolutions were passed without any rejections[53]. - The company has established independent financial and operational structures to maintain its independence from controlling shareholders[75]. - The company emphasizes the importance of independent decision-making in financial matters and the establishment of a complete governance structure[75]. - The company has committed to avoiding any business activities that may compete with its operations, ensuring no conflicts of interest arise[75]. Legal and Compliance Issues - The company has initiated legal proceedings to recover 2,629.30 million RMB in transaction intention fees from parties involved in a terminated asset restructuring agreement[50]. - The company has unresolved personal income tax liabilities amounting to RMB 143,990.00 and late fees of RMB 265,517.56 as of the report approval date[84]. - The company has reported no significant non-operating fund occupation by controlling shareholders or related parties during the reporting period[85]. - The company has no significant litigation or arbitration matters pending that have not been disclosed in temporary announcements[88]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies as part of its strategic initiatives[104]. - The company aims to improve its financial performance in the second half of 2024 by focusing on operational efficiency and cost management[130].